Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,636 | 264 | 99.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.5% |
| Education | $0.65 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $649.10 | 32 | $0 (2024) |
| Indivior Inc. | $549.99 | 28 | $0 (2024) |
| Novo Nordisk Inc | $494.14 | 26 | $0 (2024) |
| PFIZER INC. | $271.52 | 17 | $0 (2024) |
| Lilly USA, LLC | $262.55 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $232.49 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $223.14 | 13 | $0 (2022) |
| GlaxoSmithKline, LLC. | $195.35 | 13 | $0 (2024) |
| Amgen Inc. | $189.96 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168.33 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,174 | 66 | ABBVIE INC. ($186.05) |
| 2023 | $656.17 | 36 | ABBVIE INC. ($168.80) |
| 2022 | $412.90 | 23 | ABBVIE INC. ($140.55) |
| 2021 | $708.90 | 43 | AbbVie Inc. ($153.70) |
| 2020 | $319.78 | 21 | AstraZeneca Pharmaceuticals LP ($69.21) |
| 2019 | $461.23 | 29 | Indivior Inc. ($145.25) |
| 2018 | $580.66 | 30 | Novo Nordisk Inc ($220.03) |
| 2017 | $347.81 | 18 | Indivior Inc. ($141.58) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/16/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: OUD | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardio-renal | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: VACCINES | ||||||
| 10/02/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: OUD | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: DIABETES | ||||||
| 09/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.84 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $4.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.74 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.88 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 596 | 912 | $87,873 | $45,332 |
| 2022 | 9 | 275 | 394 | $40,352 | $21,360 |
| 2021 | 8 | 278 | 407 | $42,861 | $23,693 |
| 2020 | 11 | 411 | 604 | $63,325 | $29,752 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 170 | $28,123 | $12,877 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $13,206 | $11,170 | 84.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 205 | $25,010 | $10,477 | 41.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 72 | $5,156 | $3,052 | 59.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $3,852 | $2,589 | 67.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 62 | $3,596 | $1,999 | 55.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $2,184 | $1,202 | 55.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 59 | 71 | $923.00 | $596.40 | 64.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 36 | 60 | $2,013 | $571.20 | 28.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 40 | $2,200 | $386.65 | 17.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $792.00 | $208.10 | 26.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 19 | 20 | $441.00 | $122.20 | 27.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $169.00 | $44.33 | 26.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 16 | $208.00 | $35.20 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 101 | $16,665 | $8,157 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $7,100 | $6,131 | 86.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 81 | $9,684 | $4,021 | 41.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 15 | $1,541 | $1,022 | 66.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $2,080 | $884.05 | 42.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 20 | $1,040 | $546.52 | 52.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 38 | $1,254 | $364.29 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 54 | $702.00 | $159.72 | 22.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 22 | $286.00 | $75.38 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 128 | $21,120 | $10,240 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 54 | 54 | $7,668 | $6,750 | 88.0% |
About Dr. Lenora Hirschler, M.D
Dr. Lenora Hirschler, M.D is a Family Medicine healthcare provider based in Goshen, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801871694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lenora Hirschler, M.D has received a total of $4,662 in payments from pharmaceutical and medical device companies, with $1,174 received in 2024. These payments were reported across 266 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,636).
As a Medicare-enrolled provider, Hirschler has provided services to 1,560 Medicare beneficiaries, totaling 2,317 services with total Medicare billing of $120,136. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Goshen, IN
- Active Since 12/14/2005
- Last Updated 03/18/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801871694
Products in Payments
- VRAYLAR (Drug) $434.56
- SUBLOCADE (Drug) $382.66
- Ozempic (Drug) $366.64
- UBRELVY (Drug) $226.49
- ENTRESTO (Drug) $223.14
- JARDIANCE (Drug) $197.21
- SUBOXONE SUBLINGUAL FILM (Drug) $167.33
- REXULTI (Drug) $146.63
- MOUNJARO (Drug) $146.34
- Otezla (Drug) $131.29
- TRELEGY ELLIPTA (Drug) $110.92
- Kerendia (Drug) $108.91
- NURTEC ODT (Drug) $96.64
- AIRSUPRA (Drug) $95.55
- FARXIGA (Drug) $82.93
- Vivitrol 380 mg (Drug) $74.30
- ELIQUIS (Drug) $70.92
- YUPELRI (Drug) $61.19
- TRULICITY (Drug) $56.93
- TOUJEO (Drug) $55.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goshen
Andrew Hirsch, Do, DO
Family Medicine — Payments: $18,198
Dr. Michelle Shelly, Md, MD
Family Medicine — Payments: $10,377
Dr. Laura Munkel, M.d, M.D
Family Medicine — Payments: $6,171
Timothy Nush, Md, MD
Family Medicine — Payments: $4,597
Dr. Thomas Pechin, M.d, M.D
Family Medicine — Payments: $3,866
John Carey, M.d, M.D
Family Medicine — Payments: $3,321